BR112013017961A2 - antígeno tripleto para treponema pallidum - Google Patents

antígeno tripleto para treponema pallidum

Info

Publication number
BR112013017961A2
BR112013017961A2 BR112013017961A BR112013017961A BR112013017961A2 BR 112013017961 A2 BR112013017961 A2 BR 112013017961A2 BR 112013017961 A BR112013017961 A BR 112013017961A BR 112013017961 A BR112013017961 A BR 112013017961A BR 112013017961 A2 BR112013017961 A2 BR 112013017961A2
Authority
BR
Brazil
Prior art keywords
treponema pallidum
triplet antigen
triplet
antigen
pallidum
Prior art date
Application number
BR112013017961A
Other languages
English (en)
Inventor
Zheng Jian
Yang Jianping
Yura Renee
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of BR112013017961A2 publication Critical patent/BR112013017961A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BR112013017961A 2011-01-13 2012-01-13 antígeno tripleto para treponema pallidum BR112013017961A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161432570P 2011-01-13 2011-01-13
PCT/US2012/021323 WO2012097304A2 (en) 2011-01-13 2012-01-13 Treponema pallidum triplet antigen

Publications (1)

Publication Number Publication Date
BR112013017961A2 true BR112013017961A2 (pt) 2017-07-25

Family

ID=46507695

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013017961A BR112013017961A2 (pt) 2011-01-13 2012-01-13 antígeno tripleto para treponema pallidum

Country Status (8)

Country Link
US (4) US8691950B2 (pt)
EP (1) EP2663642B1 (pt)
JP (1) JP5911889B2 (pt)
CN (2) CN108085330A (pt)
BR (1) BR112013017961A2 (pt)
CA (1) CA2824758C (pt)
RU (1) RU2588656C2 (pt)
WO (1) WO2012097304A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140186861A1 (en) * 2011-07-11 2014-07-03 Uvic Industry Partnerships Inc. Soluble treponema pallidum protein tp0453, tp0453-tp0326 fusion protein, and use in syphilis diagnosis
CN107533060B (zh) 2015-03-10 2019-11-05 生物辐射实验室股份有限公司 组合密螺旋体和非密螺旋体梅毒测试
CN109868240B (zh) * 2019-03-07 2020-11-27 北京新创生物工程有限公司 一种梅毒螺旋体p15-17-47突变体、编码基因、重组载体、重组工程菌及其应用与制备方法
CN110305927B (zh) * 2019-08-07 2023-03-28 郑州伊美诺生物技术有限公司 利用重组大肠杆菌发酵制备包被tp抗原的方法
CN110981947B (zh) * 2019-12-16 2021-10-08 四川安可瑞新材料技术有限公司 梅毒螺旋体tp47重组抗原的制备及应用
CN115397465A (zh) * 2020-04-24 2022-11-25 美国西门子医学诊断股份有限公司 用于针对抗体的免疫测定的校准和质量控制试剂
EP4138915A4 (en) * 2020-04-24 2024-04-24 Siemens Healthcare Diagnostics, Inc. COMPOSITIONS, KITS AND METHODS FOR ANTIMICROBIAL SEROLOGY TESTS USING ANTI-HUMAN IMMUNOGLOBULIN ANTIBODIES
CN111575308B (zh) * 2020-05-25 2021-12-03 四川安可瑞新材料技术有限公司 梅毒螺旋体重组嵌合抗原及其制备方法、用途
CN113004380B (zh) * 2021-02-18 2022-06-28 青岛硕景生物科技有限公司 一种梅毒螺旋体重组抗原、制备及应用
CN114163539A (zh) * 2021-12-14 2022-03-11 青岛硕景生物科技有限公司 Tp重组抗原及其制备方法和应用
CN114703154B (zh) * 2022-03-30 2024-01-09 云南大学 一种多肽、含有其的蛋白及应用
CN118240037A (zh) * 2022-12-23 2024-06-25 菲鹏生物股份有限公司 用于检测梅毒螺旋体抗体的重组抗原及其用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472160B2 (en) * 1919-09-08 2002-10-29 Fujirebio Inc. Immunoassay device and immunoassay method using the same
US4514498A (en) 1982-05-26 1985-04-30 The Board Of Regents, The University Of Texas System Hybrid cell lines producing monoclonal antibodies directed against Treponema
US4740467A (en) 1982-05-26 1988-04-26 Board Of Regents, The University Of Texas Methods for diagnosing syphilis
US5342921A (en) 1985-03-28 1994-08-30 Chiron Corporation Superoxide dismutase fusion polypeptides for expression of mammalian proteins
US5350842A (en) * 1986-09-30 1994-09-27 Board Of Regents, The University Of Texas System DNAs encoding Treponema pallidum antigens
US5681934A (en) 1986-09-30 1997-10-28 Board Of Regents, The University Of Texas System 47-kilodalton antigen of Treponema pallidum
US4868118A (en) 1986-09-30 1989-09-19 Board Of Regents, The University Of Texas System Cloning and expression of the 47-kilodalton antigen of treponema pallidum
KR930703613A (ko) 1991-01-25 1993-11-30 챨스 엠. 브록 시료 희석물중 과산화물 디스뮤타제의 용도
JP3688290B2 (ja) * 1991-11-21 2005-08-24 コモン サーヴィシス エージェンシー C型肝炎ウイルス検査
US5578456A (en) 1994-02-28 1996-11-26 Fujirebio Inc. Anti-treponema pallidum antibody immunoassay
DE19536166C1 (de) 1995-09-29 1997-03-06 Siegfried Dr Krell Verfahren zur Bestimmung von Antikörpern gegen Treponema pallidum (Syphilis)
JP3533857B2 (ja) * 1995-12-25 2004-05-31 富士レビオ株式会社 梅毒トレポネマ融合抗原及び該融合抗原を用いた抗梅毒トレポネマ抗体の測定方法
CA2193870C (en) 1995-12-25 2000-07-18 Nobuyuki Ise Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen
JPH1090264A (ja) * 1996-09-11 1998-04-10 Sekisui Chem Co Ltd 免疫学的診断試薬
AU722630B2 (en) * 1997-02-14 2000-08-10 Higeta Shoyu Co., Ltd. Modified Treponema pallidum-derived antigen protein
JPH10225294A (ja) * 1997-02-14 1998-08-25 Higeta Shoyu Co Ltd 融合タンパク質、それをコードするdna、そのdnaを含む組換えベクター、その組換えベクターを含む形質転換体、融合タンパク質の製造法、抗トレポネーマ・パリダム抗体の測定法及び測定用試薬、梅毒感染診断薬並びに抗トレポネーマ・パリダム抗体の製造法
BRPI0111731C1 (pt) * 2000-06-15 2021-07-27 Chiron Corp suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico
CN1490411A (zh) * 2002-10-19 2004-04-21 厦门市厦大建南抗性基因有限公司 一种从人体组织中获得人铜锌超氧化物歧化酶基因的方法
WO2006138324A2 (en) * 2005-06-14 2006-12-28 Baylor College Of Medicine Treponema pallidum antigens for vaccine development and diagnostic tests
US20090104650A1 (en) 2007-09-14 2009-04-23 Cryo-Cell International, Inc. Infectious diseases testing of menstrual fluid, endometrial/menstrual cells, amniotic fluid, umbilical cord blood or other samples
CN101918834B (zh) * 2008-01-07 2014-05-28 奥索临床诊断有限公司 用于同时分析能够彼此络合的蛋白质的校准物/对照物
RU2397178C1 (ru) * 2009-02-27 2010-08-20 Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса

Also Published As

Publication number Publication date
US8691950B2 (en) 2014-04-08
CN108085330A (zh) 2018-05-29
US20120237956A1 (en) 2012-09-20
RU2013137760A (ru) 2015-02-20
US20160115206A1 (en) 2016-04-28
CA2824758C (en) 2019-06-04
WO2012097304A3 (en) 2012-09-13
US9221884B2 (en) 2015-12-29
CA2824758A1 (en) 2012-07-19
WO2012097304A2 (en) 2012-07-19
US20180141980A1 (en) 2018-05-24
JP5911889B2 (ja) 2016-04-27
US9902755B2 (en) 2018-02-27
US10125177B2 (en) 2018-11-13
EP2663642B1 (en) 2017-03-01
JP2014506134A (ja) 2014-03-13
EP2663642A4 (en) 2014-11-05
US20140178907A1 (en) 2014-06-26
EP2663642A2 (en) 2013-11-20
RU2588656C2 (ru) 2016-07-10
CN103298941A (zh) 2013-09-11

Similar Documents

Publication Publication Date Title
IL290848A (en) Formulation for anti-antibody alpha 4 in cell 7
IL275038A (en) Formulation for anti-antibody alpha 4 in cell 7
BR112013017961A2 (pt) antígeno tripleto para treponema pallidum
DK3275892T3 (da) Præfusions-rsv-f-antigener
CO6811812A2 (es) Anticuerpo anti-b7-h3
CO7020871A2 (es) Anticuerpos anti-il-36r
CR20140127A (es) Anticuerpo anti-abtcr
BRDI7106210S (pt) Configuração aplicada para lâmina para microscópio
CO6890075A2 (es) Alcoholimetro calibrable
CO6801637A2 (es) Formulaciones de anticuerpos
BR112013021944A2 (pt) dispositivo para dirigir veículos
CO6841994A2 (es) Anticuerpos
PL2797423T3 (pl) Emulsja wegańska
ES1074173Y (es) Pieza para solados
ES1075221Y (es) Vallado cortavientos para parques termosolares
DK2741730T5 (da) Multipel emulsion
ES1075480Y (es) Dispositivo para escaneado 3d de arquetas de alcantarilla
DOP2011000313A (es) Anticuerpos especificos para caderin-17
ES1075463Y (es) Dispositivo de punteria para escopeta
ES1076357Y (es) Dispositivo antideslumbramiento para vehiculos.
ES1075861Y (es) Soporte inamovible para jamones
FR2981558B1 (fr) Appui-tete pour fauteuil roulant
FI20115682A0 (fi) 3D integraatio

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired
B350 Update of information on the portal [chapter 15.35 patent gazette]